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Abstract A loop-mediated isothermal amplification
(LAMP) method with a real-time monitoring system was
developed for the detection of porcine circovirus type 1
(PCV1) in commercial swine vaccines. This method was
highly specific for PCV1. No cross-reaction to porcine
circovirus type 2, porcine parvovirus, pseudorabies virus,
classical swine fever virus, and porcine reproductive and
respiratory syndrome virus was observed. The analytical
sensitivity of the LAMP for PCV1 DNA was 10 copies/μl
in the case of positive recombinant plasmid comparable to
that obtained from the nested polymerase chain reaction
(nested PCR). Furthermore, 25 commercial swine vaccines
were tested by both the LAMP and the nested PCR, and
three of them were tested positive for PCV1 DNA. These
results indicate that PCV1 DNA can be real-time detected
by the LAMP; the method was highly specific, sensitive,
and rapid for the detection of PCV1 DNA, particularly in
commercial swine vaccines.
Abbreviations
PCV1 Porcine circovirus type 1
PCV2 Porcine circovirus type 2
PMWS Post-weaning multisystemic wasting syndrome
PDNS Porcine dermatitis and nephropathy syndrome
PCVAD Porcine circovirus associated disease
PNP Proliferative and necrotizing pneumonia
ORF Open reading frame
LAMP Loop-mediated isothermal amplification
PCR Polymerase chain reaction
PPV Porcine parvovirus
PRRSV Porcine reproductive and respiratory syndrome
virus
CSFV Classic swine fever virus
PRV Pseudorabies virus
Porcine circovirus (PCV) belongs to the genus Circovirus
of the family Circoviridae (Finsterbusch and Mankertz
2009). PCV is non-enveloped, 17 nm in size, and contains a
circular single-stranded DNA genome with two major open
reading frames, ORF1 and ORF2 (Finsterbusch and
Mankertz 2009). ORF1 is believed to encode replication-
associated proteins (Cheung 2003; Finsterbusch et al. 2005;
Mankertz et al. 2004). ORF2 encodes a major capsid
protein containing immunologically important domains
associated with virus neutralization (Lekcharoensuk et al.
2004; Mahé et al. 2000). PCV has been divided into two
distinct clusters, PCV1 and PCV2 (An et al. 2009;
Calsamiglia et al. 2002; Cságola et al. 2008; Muhling et
al. 2006). PCV2 can be distinguished from PCV1 on the
basis of genome sequence and antigenicity (Calsamiglia et
al. 2002; Mahe et al. 2000; Muhling et al. 2006).
PCV1 has been isolated from contaminated PK-15 cells
(Dulac and Afshar 1989; Tischer et al. 1995) and is not
considered to be pathogenic for pigs (Allan et al. 1995;
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DOI 10.1007/s12223-011-0072-7Tischer et al. 1986). Presence of PCV1 in domestic pigs is
not surprising because a number of viral vaccines are
manufactured from porcine-derived components, which
may be contaminated with PCV1 (Quintana et al. 2006).
Meanwhile, contamination of PCV1 in vaccine products is
unacceptable, and such products should not be used in pig
farms (Quintana et al. 2006). PCV2, unlike PCV1, is
pathogenic to pigs and is considered as the primary
causative agent of post-weaning multisystemic wasting
syndrome (PMWS), porcine dermatitis and nephropathy
syndrome (PDNS), porcine respiratory disease complex
(PRDC), proliferative and necrotizing pneumonia (PNP),
and porcine circovirus-associated disease (PCVAD) (Chae
2005; Kixmöller et al. 2008; Wang et al. 2004). Recently,
the emergence of PCV2 infection has led to a significant
increase in post-weaning mortality and high economic
losses for the swine industry around the world (Horlen et
al. 2007; Kixmöller et al. 2008).
Loop-mediated isothermal amplification (LAMP) is an
excellent diagnostic tool for detecting specific nucleic acid
sequences in clinical samples (Alhassan et al. 2007; Chen et
al. 2008; de Castro et al. 2008; Han et al. 2007; Notomi et
al. 2000). This technique is highly specific, relatively fast,
and easy to perform. In the LAMP reaction, a DNA sample
is incubated with specific LAMP primer sets, Bst DNA
polymerase with strand-displacement activity, and sub-
strates at a constant temperature between 60°C and 65°C
(Alhassan et al. 2007; Chen et al. 2008; Ihira et al. 2004;
Nagashima et al. 2007). The LAMP has been used
successfully to detect PCV2 in field samples (Chen et al.
2008), but has not yet been developed to detect PCV1 in
commercial swine vaccines. The aim of this study was to
develop a LAMP with a real-time monitoring system for the
detection of PCV1 in commercial swine vaccines.
Materials and methods
Commercial porcine vaccines and viruses A total of 25
commercially available porcine vaccines were obtained
from licensed manufacturers and pharmaceutical suppliers
in Taiwan (Table 1). Viral DNA was extracted from each
vaccine using the QIAamp DNA Extraction Kit (Qiagen,
USA) according to the manufacturer’s instructions. For
evaluating specificity of the LAMP, 21 virus isolates,
comprising six PCV1, five PCV2, two porcine parvovirus
(PPV), three pseudorabies virus (PRV), three classic swine
fever virus (CSFV), and two porcine reproductive and
respiratory syndrome virus (PRRSV) isolates, were used;
all of the isolates were previously identified by determining
their partial nucleotide sequences (Wang et al. 2004, 2008;
Huang et al. 2009). The DNA of PCV1, PCV2, PPV, PRV,
and cDNA of CSFVand PRRSV isolates were produced as
described previously (Huang et al. 2009; Wang et al. 2004,
2008)
Primers Specific primer sets of the LAMP for PCV1
detection were designed by PrimerExplorer V4 software
(http://primerexplorer.jp/elamp4.0.0/index.html)b a s e do n
different reference PCV1 isolates (GenBank accession no.
AF012107, AY184287, AY219836, AY660574,
DQ472013, DQ659154, EF493843, FJ475129, and
GU722334). The primer sets consisted of two outer primers
(F3 and B3) and two inner primers (FIP and BIP) targeting
a conserved region within the PCV1 ORF2 gene. To further
validate the LAMP, the primers PCV-F1, PCV-R1, PCV-F2,
and PCV-R2 were used for nested polymerase chain
reaction (nested PCR) targeting the conserved region of
the PCV1 ORF2 gene (Victoria et al. 2010). Nucleotide
sequences and locations of the primers are shown in
Table 2.
LAMP reaction A2 5 - μl reaction mixture consisted of
12.5 μl of 2× LAMP reaction buffer (Eiken Chemical,
Japan), 8 U Bst DNA polymerase (New England Biolabs,
USA), 2 μl of the extracted target DNA sample, 40 pmol
each of FIP and BIP primers, and 5 pmol each of F3 and B3
primers. The LAMP reaction was conducted by incubating
the reaction mixture at 60°C for 60 min and then
inactivating the Bst DNA polymerase at 80°C for 2 min.
The reaction was monitored in real-time at 6-s intervals by
measuring the turbidity at A650 using a Loopamp real-time
turbidimeter (LA-320; Eiken Chemical, Japan). The cutoff
turbidity was set at 0.1 turbidity units and was determined
by analyzing negative controls in replicates. A sample with
turbidity remaining below 0.1 turbidity units throughout the
60-min incubation period was considered to be negative for
PCV1 DNA. If the turbidity of a sample increased above
0.1 turbidity units within the 60-min incubation period, it
was considered to be positive, indicating contamination
with PCV1 DNA. The LAMP amplicons were further
analyzed by electrophoresis through a 2% agarose gel
containing 0.5 mg/ml SYBR Safe DNA gel stain (Invi-
trogen, USA) in Tris–acetate–EDTA (ethylenediamine
tetra-acetic acid) buffer.
Nested PCR reaction A total of 25 PCR reaction mixtures
of the first round PCR in the nested PCR consisted of 2.5 μl
of 10× buffer (100 mmol/l Tris–HCl at pH 8.8, 500 mmol/
l KCl, 15 mmol/l MgCl2, 1% Triton X-100), 1.25 μmol/
l each of four nucleoside triphosphates, 20 μmol/l of each
primer, 0.5 μl of DNA polymerase POWER TAQ (2 U/μl;
Bertec, Taipei, Taiwan), and 2 μl of the DNA sample. The
first round PCR was performed at 95°C for 5 min, followed
by 30 cycles of denaturation at 95°C for 20 s, annealing at
55°C for 30 s, and extension at 72°C for 30 s. Finally, the
484 Folia Microbiol (2011) 56:483–489samples were subjected to a terminal extension step at 72°C
for 10 min. From this reaction, 2 μl of the first round PCR
product was used as a template for the nested PCR. In the
nested PCR, 25 μl of reaction mixture consisted of 2.5 μlo f
10× buffer (100 mmol/l Tris–HCl at pH 8.8, 500 mmol/l KCl,
15 mmol/l MgCl2, 1% Triton X-100), 1.25 μmol/l each of
four nucleoside triphosphates, 20 μmol/l of each primer, and
0.5 μl of DNA polymerase POWER TAQ (2 U/μl; Bertec,
Taiwan). The nested PCR was performed at 95°C for 5 min,
followed by 30 cycles each of denaturation at 95°C for 20 s,
annealing at 55°C for 20 s, and extension at 72°C for 20 s.
Finally, the samples were subjected to a terminal extension
step at 72°C for 10 min. Amplicon of the nested PCR were
analyzed by electrophoresis through a 2% agarose gel as
described above.
Construction of recombinant plasmids Full-length ORF2
gene of PCV1 (GenBank accession no. AY219836) was
amplified as described previously (Lekcharoensuk et al.
2004). The amplicon was ligated into the pCRII-TOPO
plasmid that was supplied with the Dual Promoter TOPO
TA Cloning Kit (Invitrogen, USA). Top10F
® Escherichia
coli competent cells (Invitrogen, USA) were transformed
with the recombinant plasmid according to the manufac-
turer’s instructions. The inserted target gene carried by the
recombinant plasmid was directly sequenced as described
previously (Wang et al. 2004). The recombinant plasmid
was quantified by measuring its absorbance A260 on a
U2100 pro UV/Vis spectrophotometer (General Electronic
Healthcare, Singapore) and diluted to 10
7 copies/μlt o
develop a standard curve for evaluating the analytical
sensitivity of the LAMP.
Analytical specificity and sensitivity of the LAMP To
determine the analytical specificity of the LAMP, DNA
samples extracted from the 21 virus isolates were tested by
Table 1 Detection of PCV1 DNA in commercial vaccines by the
LAMP and the nested PCR
Manufacturer Agent LAMP Nested
PCR
A CSFV −−
AP R V −−
B CSFV + +
BP R V −−
C CSFV + +
CP R V , B. bronchiseptica, P.
multocida
−−
D CSFV −−
D FMDV −−
E CSFV + +
EP R V −−
F CSFV −−
FP R V , E. rhusiopathiae, P.
multocida, M. hyopneumoniae
−−
F FMDV −−
G FMDV −−
G PRRSV −−
H FMDV −−
HP R V , M. hyopneumoniae, E.
coli
−−
I PRRSV −−
J PPV −−
J FMDV −−
K FMDV −−
L PPV −−
M PRV, PPV, E. rhusiopathiae −−
N CSFV −−
N FMDV −−
CSFV classic swine fever virus, PRV pseudorabies virus, FMDV foot-
and-mouth disease virus, PRRSV porcine reproductive and respiratory
syndrome virus, PPV porcine parvovirus
Table 2 Oligonucleotide primer sets used for the LAMP and nested PCR
Primer Position
a Type Sequence (5′–3′)
LAMP F3 1,210–1,228 Forward outer TTG TTT GGT CCA GCT CAG G
B3 1,400–1,381 Backward outer CAG AGA CCC CAT CAC CTC TA
FIP
b 1,289–1,271, 1,230–1,248 Forward inner CTC CTC CTC CCG CCA CAC CAT A
F1c-TTTT-F2 -TTTT
a- TTG GGG GTG AAG TAC CTG G
BIP
b 1,306–1,327, 1,372–1,354 Backward inner CAT AGG CCA AGT TGG TGG ACG G
B1c-TTTT-B2 -TTTT
a- GGT GTT GGG TCC ACT GTT G
Nested PCR PCV-F1 1,146–1,167 First forward TTG GTG TGG GTA TTT AAA TGG A
PCV-R1 1,677–1,659 First reverse GCA GCC ATC TTG GAA ACA T
PCV-F2 1,297–1,318 Second forward TAT AGG GGT CAT AGG CCA AGT T
PCV-R2 1,452–1,431 Second reverse CCC TAC CTT TCC AAT ACT ACC G
aLocation of the primers based on the nucleotide sequence of the ORF2 gene of PCV1 (GenBank accession no. AY219836)
bBoth inner primers FIP and BIP contained two binding regions and were connected by a TTTT bridge
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(SPF) swine tissue samples was used as the negative
control. To evaluate the analytical sensitivity of the assay,
10-fold serial dilutions of the recombinant plasmid were
performed to prepare the dilutions at concentration from
10
7 copies/μl to 1 copy/μl, and each dilution was tested by
both the LAMP and the nested PCR (Victoria et al. 2010).
Forquantificationofthedilutedsamples,astandardcurvewas
generated for the LAMP, with serial 10-fold dilutions of the
recombinantplasmidthatwerepositiveforPCV1DNAonthe
X-axis and the time of positivity (min) on the Y-axis.
Evaluation of LAMP with commercial swine vaccines Two
batches of each vaccine were tested for detection of PCV1
DNA by the LAMP and the nested PCR, respectively. To
evaluate the vaccine matrices for interference or inhibition
of the LAMP reaction, all extracted DNA of tested vaccine
samples were spiked with plasma containing the recombi-
nant plasmid. The final concentration of the recombinant
plasmid for each spiked vaccine sample was 10
6 copies/ml.
Detection of PCV1 DNA for each spiked vaccine sample
was performed by the LAMP as an internal control.
Results
The analytical specificity of LAMP was evaluated using
DNA extracted from PCV1, PCV2, PPV, and PRV, and
cDNA derived from CSFV and PRRSV. PCV1 DNA was
successfully detected, and a ladder-like amplicon was
generated (Fig. 1). The LAMP amplified the PCV1 target
gene, but not the nucleic acids extracted from PCV2, PPV,
PRV, CSFV, and PRRSV (Fig. 1).
By testing 10-fold serial dilutions (10
7 copies/μlt o
1 copy/μl) of the recombinant plasmid, the LAMP
demonstrated a detection limit of 10 copies (Fig. 2, lane
7), comparable to the nested PCR (10 copies; Fig. 2, lane
15). The standard curve for LAMP was generated from the
amplification plots of the 10-fold serial dilutions of the
recombinant plasmids (10
7 copies/μl to 10 copies/μl) vs.
time (min) (Fig. 3a). A linear regression line with a
coefficient of r
2=0.97 was plotted for the LAMP (Fig. 3b).
PCV1 DNA was detected in three commercial CSFV
vaccines by the LAMP and the nested PCR (Table 2).
These vaccines were manufactured by three different
commercial companies (B, C, and E). All extracted DNA
of tested vaccine samples were spiked with PCV1
recombinant plasmids and yielded positive results for
detection of PCV1 DNA by the LAMP (data not shown).
These results also indicated that inhibition was not
observed in the extracted DNA of 25 commercial swine
vaccine samples.
Discussion
The LAMP developed in this study was rapid for the
detection of PCV1 DNA. The products generated by this
method can be analyzed not only by conventional agarose
gel electrophoresis but also spectrophotometry, which
enables real-time analysis and quantification of the ampli-
cons in commercial swine vaccines. Amplification of a
specific genomic region by conventional or nested PCR
alone, or by PCR in combination with gene sequencing, has
long been used to confirm the accuracy of amplicons
generated by PCR (Muhling et al. 2006; Victoria et al.
2010). However, with or without gene sequencing, con-
Fig. 1 Analytical specificity of
the LAMP was observed using
agarose gel electrophoresis.
Lane M 2,000–100 bp ladder
marker (50 U/μl; Protech,
Taiwan); lanes 1–7 extracted
DNA of PCV1, PCV2, PPV,
PRV, cDNA of CSFV, PRRSV,
and negative control,
respectively
486 Folia Microbiol (2011) 56:483–489ventional detection procedures for PCV1 require several
hours to complete. In contrast, DNA detection with the
LAMP was much faster than with conventional PCR or
nested PCR. After preparation of the sample DNA, the
Fig. 2 Analytical sensitivities of the LAMP (lanes 1–8) and the
nested PCR (lanes 9–16) were compared by detecting 10-fold serial
dilutions of the recombinant plasmid (10
7 copies/μl to 1 copy/μl) by
agarose gel electrophoresis. Lane M 2,000–100 bp ladder marker
(50 U/μl; Protech, Taiwan). The PCR products of lanes 9–15 were
155 base pairs (bp) in length
Fig. 3 Analytical sensitivity of
the LAMP (a) was performed by
real-time monitoring with
10-fold serial dilutions of the
recombinant plasmid: 10
7
copies/μl to 1 copy/μl and
negative control (NT). The linear
function fitted to the plot of the
mean threshold time against the
log of the input PCV1 the
recombinant plasmid is also
shown (b)
Folia Microbiol (2011) 56:483–489 487LAMP could be completed in approximately 1 h, whereas
other methods required several hours to a few days.
Furthermore, PCV1 DNA could be specifically and
sensitively amplified using the two LAMP primer sets; no
amplification was observed when the method was used to
detect nucleic acids of PCV2, PPV, PRV, CSFV, FMDV,
and PRRSV. These results indicate the specificity and wide
applicability of our LAMP method in the detection of viral
contaminants in commercial swine vaccines. The sensitivity
of the LAMP was equivalent to that of the nested PCR. Our
results showed that the LAMP is highly sensitive and can
detect small amounts of PCV1 DNA present in samples.
This method enables the detection and quantification of
PCV1 DNA in commercial swine vaccines.
In this study, using the LAMP, we found that three
commercially available CSFV vaccines were contaminated
with PCV1 DNA, although the source of PCV1 DNA
contamination in some commercial porcine vaccines has
remained unknown. Recently, PCV1 DNA was also found
in two commercial human rotavirus vaccines (Baylis et al.
2011; Victoria et al. 2010). Although PCV1 is not regarded
as a potential pathogen in humans (Victoria et al. 2010),
avoiding virus contamination during the process of vaccine
production is absolutely essential. The detected PCV1 DNA
may originate from the cell lines used for vaccine
production (Quintana et al. 2006). Presence of PCV1
DNA in the vaccines does not necessarily imply that
infectious PCV1 particles are present in the vaccines. The
contaminating PCV1 may have been inactivated during the
manufacturing process or may have been present in the live
vaccine products in too small amounts to cause an infection
(Quintana et al. 2006). Regardless of whether the contam-
inant PCV1 was alive or inactivated, the presence of viral
DNA other than the vaccine DNA itself is absolutely
unacceptable. To fulfill this requirement, a rapid, specific,
and sensitive method such as LAMP can be easily
incorporated in the production process to screen for PCV1
contamination in vaccines and in cell lines used for
cultivation of the vaccine viruses.
The spiking study was performed by deliberately spiking
PCV1 virus into the vaccine samples to account for
inhibition; this avoids a potential problem that may result
in the under-detection of PCV1 (i.e., false negatives). A
previous study indicated that some human medicines
contain heparin, adjuvant, phenol, or formaldehyde, which
are common PCR inhibitors and always remain with the
extracted nuclear acid (Yokota et al. 1999). In this study, no
evidence of inhibition has been observed in any extracted
DNA of swine vaccine sample for spiked recombinant
plasmids. However, this was necessary to perform spiking
studies as an internal control for the LAMP reaction; this
assessed individual vaccine matrices that may be the cause
of amplification product inhibition.
In conclusion, our LAMP method enables the detection of
small amounts of PCV1 DNA. This method can be used to
rapidly detect cell lines and commercial swine vaccines for
PCV1 contamination with high sensitivity and specificity.
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